Optimal use of topical agents for allergic conjunctivitis

Area of Science:

• Ophthalmology
• Allergology
• Pharmacology

Background:

• Allergic conjunctivitis is a common cause of red-eye syndrome.
• Topical treatments are preferred for rapid symptom relief, but require careful agent selection to avoid irritation.
• Theoretical benefits of topical therapy include faster action and fewer systemic side effects compared to oral administration.

Purpose of the Study:

• To review pathological mechanisms, clinical overview, and diagnostic approaches for allergic conjunctivitis.
• To discuss available therapeutic options for various forms of allergic conjunctivitis.
• To present a treatment strategy based on the disorder's nature and patient expectations.

Main Methods:

• Review of pathological mechanisms and clinical presentation of allergic conjunctivitis.
• Analysis of current topical therapeutic agents and their applications.
• Development of a tiered treatment strategy for different conjunctivitis types.

Main Results:

• Seasonal/perennial conjunctivitis: decongestant/antihistamine combination for palliation, mast cell stabilizers for prophylaxis, immunotherapy for cure.
• Vernal/atopic keratoconjunctivitis: long-term decongestant/antihistamine use, topical corticosteroids for flares, mast cell stabilizers (lodoxamide) for prophylaxis, surgery for complications.
• Giant papillary/contact conjunctivitis: hygiene measures, sodium cromoglycate for relief, allergen avoidance, limited corticosteroid use.

Conclusions:

• A tailored approach to topical treatment is essential for managing allergic conjunctivitis effectively.
• Treatment choice depends on conjunctivitis type, symptom severity, and patient-specific factors.
• Balancing rapid symptomatic relief with long-term disease control and safety is key.